GLOBUS MEDICAL INC 4

4 · GLOBUS MEDICAL INC · Filed Sep 5, 2013

Form 4

Period: 2013-01-30

Director10% Owner

Transactions

Award
Stock Option (Right to Buy Class A Common Stock)
2013-01-30+7,500→ 7,500 total
Exercise: $12.59Exp: 2023-01-30→ Class A Common Stock (7,500 underlying)

Holdings

Class A Common Stock
(indirect: By L.P.)
7,244,201
Stock Option (Right to Buy Class A Common Stock)
Exercise: $15.34Exp: 2022-08-29→ Class A Common Stock (15,300 underlying)
15,300

Footnotes (3)

[F1]Clarus Ventures I Management, L.P. ("Clarus I Management") is the sole general partner of Clarus Lifesciences I, L.P. and Clarus Ventures I, LLC ("Clarus I GPLLC") is the sole general partner of Clarus I Management. Mr. Liptak is a managing director of Clarus I GPLLC. As a managing director of Clarus I GPLLC, Mr. Liptak has shared voting and disposition power related to these shares and disclaims beneficial ownership of these shares.
[F2]These options were granted on January 30, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
[F3]These options vest over a three-year period with one-twelfth (1/12) of the options granted vesting on December 31, 2012, and the balance of the options granted vesting ratably on a quarterly basis over the following 11 quarters.

Documents

1 file